Adult onset still disease diagosis and management
Reading File
Finding Sources
Searching PubMed
"adult-onset Still disease" AND diagnosis AND management
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Loading Image
I now have all the material I need for a comprehensive answer. Let me compile it.
Adult-Onset Still's Disease (AOSD): Diagnosis and Management
Overview
Adult-onset Still's disease (AOSD) is a rare systemic autoinflammatory disorder of unknown etiology. It is the adult equivalent of systemic juvenile idiopathic arthritis (sJIA). The condition is often difficult to diagnose because it is a diagnosis of exclusion - no single test is pathognomonic. It primarily affects young adults (most onset before age 30), with a slight female predominance. Rarely presents after age 60.
Pathogenesis
The etiology is unknown but involves dysregulated innate immunity with:
- Elevated serum levels of IL-1, IL-6, IL-18, TNF, and IFN-γ
- Possible triggers: infectious agents (enteroviruses, herpesviruses, bacteria causing pneumonia/enterocolitis)
- HLA antigen associations suggest a genetic component, though familial cases are uncommon
Classic Clinical Triad
| Feature | Details |
|---|---|
| Quotidian fever | Spiking >39°C, typically late afternoon/early evening, resolves within hours |
| Arthritis | 65-100% of patients; knees, wrists, ankles most common; symmetric pattern |
| Skin rash | Salmon-pink macular/urticarial eruption, concurrent with fever spikes, often transient |
The Characteristic Rash
The skin eruption is the most distinctive sign:
- Salmon-pink macules or slightly papular lesions
- Evanescent - present during fever spike, disappears as fever resolves
- Usually non-pruritic
- Favors trunk and extremities (including palms/soles)
- Koebner phenomenon present (lesions appear at pressure sites)
Atypical variants (seen in >50% in some Asian series):
- Persistent pruritic papules and plaques (most common atypical form, 75% of atypical cases)
- Flagellate erythema
- Dermatomyositis-like eyelid edema
- Lichenoid papules, vesiculopustular eruptions
- Persistent, atypical lesions are associated with a worse prognosis
Other Systemic Features
- Constitutional: Sore throat (often the initial symptom), arthralgias, myalgias, lymphadenopathy
- Hepatosplenomegaly: Hepatomegaly more common than splenomegaly
- Serositis: Pleuritis, pericarditis, pleural/pericardial effusions (rare)
- Carpal ankylosis: A distinctive feature of AOSD arthritis - limited range of motion with minimal pain; may also affect proximal/distal interphalangeal joints and cervical spine; MCP joints typically spared
Laboratory Findings
| Test | Finding |
|---|---|
| Ferritin | Often >4,000 ng/mL; may correlate with disease activity |
| Glycosylated ferritin fraction | <20% is characteristic (normal ~50-80%) |
| WBC | Leukocytosis (85% of patients); ≥80% PMNs in 69% |
| CRP / ESR | Elevated |
| Platelets | Elevated (thrombocytosis) |
| Liver enzymes | Elevated (transaminitis) |
| ANA / RF | Negative or low titer - an important diagnostic clue |
| Anemia | Common |
A markedly elevated ferritin (>10,000 ng/mL) with a glycosylated ferritin fraction <20% is highly suggestive of AOSD and should prompt urgent evaluation.
Diagnostic Criteria
AOSD is a diagnosis of exclusion. Two classification criteria sets are used:
Yamaguchi Criteria (1992) - Most widely used
Requires: ≥5 criteria (at least 2 major) + no exclusion criteria
| Major Criteria | Minor Criteria |
|---|---|
| Fever ≥39°C lasting ≥1 week | Sore throat / pharyngitis |
| Arthralgia lasting ≥2 weeks | Lymphadenopathy and/or splenomegaly |
| Typical salmon-pink rash (maculopapular, non-pruritic, with fever) | Abnormal liver function tests |
| Leukocytosis ≥10,000/mm³ with ≥80% PMNs | Negative ANA and RF |
Exclusion criteria: Infections, malignancies, other rheumatic diseases
Fautrel Criteria (2002) - Validated alternative
Requires: 4 major criteria OR 3 major + 2 minor criteria
| Major Criteria | Minor Criteria |
|---|---|
| Spiking fever ≥39°C | Maculopapular rash |
| Arthralgia | Leukocytosis ≥10,000/mm³ |
| Transient erythema | |
| Pharyngitis | |
| PMN count ≥80% | |
| Glycosylated ferritin fraction ≤20% |
The Fautrel criteria incorporate glycosylated ferritin (a more specific biomarker) and do not require exclusion criteria.
Disease Course Patterns
- Monocyclic (self-limited): Single episode resolving within 1 year; fever >39.5°C is predictive
- Polycyclic (intermittent): Recurrent flares separated by remissions
- Chronic persistent: Continuous disease, often arthritis-dominant; associated with thrombocytopenia
Complications
| Complication | Notes |
|---|---|
| Macrophage Activation Syndrome (MAS) / Reactive HLH | 2.85-6% of cases; life-threatening; part of hemophagocytic lymphohistiocytosis spectrum |
| Thrombotic thrombocytopenic purpura (TTP) | Rare association |
| Myocarditis | Rare but potentially life-threatening; responds to corticosteroids/immunosuppression |
| Malignancy association | 50% hematologic (lymphomas), 50% solid tumors; median detection 9 months after AOSD diagnosis; AOSD may resolve after tumor treatment |
| Cardiac tamponade | From pericarditis |
| Pulmonary arterial hypertension | Rare |
Red flags for underlying malignancy: Elevated LDH, atypical cells on CBC, elevated soluble IL-2 receptor - consider bone marrow biopsy and lymph node biopsy.
Management
Treatment follows a step-up approach based on disease severity:
Step 1: NSAIDs / Aspirin
- High-dose aspirin or NSAIDs for mild systemic disease
- Only ~20% of patients achieve adequate control with NSAIDs alone
Step 2: Corticosteroids
- Oral prednisone 40-60 mg/day for acute systemic features
- Required in the majority of patients; effective for fever, rash, and serositis
- Long-term use limited by side effects
Step 3: Conventional DMARDs
- Methotrexate is the most commonly employed second-line agent when corticosteroids cannot be tapered (particularly for persistent arthritis)
- Useful as a corticosteroid-sparing agent
Step 4: Biologic Agents (Moderate-to-Severe Disease)
Particularly for systemic inflammation without predominant joint disease:
| Biologic | Target | Notes |
|---|---|---|
| Anakinra | IL-1R antagonist | Rapid onset; used in acute severe or refractory disease |
| Canakinumab | Anti-IL-1β | Long-acting; approved for SJIA, increasingly used in AOSD |
| Tocilizumab | Anti-IL-6R | Effective for both systemic and articular disease |
| Etanercept / Adalimumab | Anti-TNF | Some response, typically less effective than IL-1/IL-6 inhibitors |
IL-1 inhibitors (anakinra, canakinumab) are particularly effective for the systemic/inflammatory phenotype, while IL-6 inhibitors (tocilizumab) work well for both systemic and articular disease. These are now increasingly used as first-line therapy for moderate-to-severe disease.
Differential Diagnosis
Conditions to exclude before diagnosing AOSD:
- Infections: Viral (EBV, CMV, HIV, parvovirus), bacterial (septicemia, endocarditis, TB)
- Malignancies: Lymphoma (especially Hodgkin's), leukemia, solid tumors
- Other autoimmune: SLE, reactive arthritis, Behcet's disease, polymyalgia rheumatica
- Schnitzler syndrome: Recurrent urticaria + fever + monoclonal IgM gammopathy + bone pain - key differentiator
- Dermatomyositis: When persistent eyelid edema or flagellate erythema present; look for myositis, specific autoantibodies, interface dermatitis on biopsy
- Systemic vasculitis
Histopathology of Skin Lesions
- Evanescent lesions: Interstitial and perivascular mixed infiltrate, neutrophil-dominant
- Persistent/atypical lesions: Epidermal involvement - acanthosis, spongiosis, necrotic keratinocytes in spinous layer
- (Not diagnostic alone; must correlate with clinical picture)
Recent Evidence (PubMed, 2026)
A 2026 systematic review (Balay-Dustrude et al., J Rheumatol, PMID: 41033820) examined clinical features and outcome measures across Still disease cohorts worldwide, noting significant heterogeneity in outcome reporting - highlighting the need for standardized metrics in AOSD research.
Sources:
- Dermatology 2-Volume Set, 5th Ed. (Elsevier), Ch. 45 - Adult-Onset Still Disease
- Fitzpatrick's Dermatology, Vols. 1-2 (McGraw-Hill), Ch. 66 - Rheumatoid Arthritis, JIA, AOSD and Rheumatic Fever
- Balay-Dustrude E et al. J Rheumatol. 2026 Feb 1. [PMID: 41033820]
Serum ferritin in adult onset stills disease
Finding Sources
Searching PubMed
"ferritin" AND "adult-onset Still disease"
Reading File
Reading File
Reading File
Finding Sources
Searching PubMed
"glycosylated ferritin" AND "Still disease"
Reading Article
Finding Sources
Reading File
Reading File
I now have comprehensive information from multiple authoritative sources. Let me compile the detailed focused answer.
Serum Ferritin in Adult-Onset Still's Disease (AOSD)
Why Ferritin is Central to AOSD
Serum ferritin is not merely an incidental finding in AOSD - it is a key diagnostic biomarker, disease activity marker, and a window into the underlying pathophysiology. Hyperferritinemia in AOSD is driven by the massively dysregulated innate immune response (macrophage/monocyte activation, cytokine storm with elevated IL-1, IL-6, IL-18, TNF, IFN-γ) that forces upregulation of ferritin synthesis as part of an acute phase response - but to a degree far exceeding ordinary inflammation.
Degree of Elevation
| Ferritin Level | Clinical Context |
|---|---|
| Normal: 12-300 ng/mL (female), 12-400 ng/mL (male) | Healthy baseline |
| 3× upper limit of normal | Elevated in ~60% of AOSD patients |
| >4,000 ng/mL | Common in active AOSD; often correlates with disease activity |
| >10,000-50,000 ng/mL | Strongly suggestive of AOSD or MAS |
| >50,000 ng/mL | Usually not hemochromatosis; points to histiocytosis or Still disease |
Serum ferritin above normal was observed in 56.4% of AOSD patients, with elevations >3× normal in 60% of cases in the largest published review.
- Fitzpatrick's Dermatology, Ch. 66
The degree of elevation in AOSD is out of proportion to what is seen in ordinary inflammatory diseases (infection, RA, SLE). This extreme hyperferritinemia is therefore a powerful discriminating feature.
The Glycosylated Ferritin Fraction - The More Specific Marker
This is the most disease-specific ferritin finding in AOSD.
Normal vs. Pathologic Glycosylation
| State | Glycosylated Ferritin Fraction |
|---|---|
| Healthy individuals | 50-80% of total serum ferritin is glycosylated |
| General inflammatory disease | Drops to 20-50% |
| AOSD | Drops to <20% - the diagnostic threshold |
Why Does Glycosylation Drop?
In AOSD, the overproduction of ferritin is so rapid and massive (driven by macrophage activation) that the normal post-translational glycosylation machinery cannot keep pace. The result is a disproportionately large pool of unglycosylated ferritin flooding the serum - detected as a low glycosylated fraction.
Clinical Utility
- A glycosylated ferritin fraction ≤20% is a major criterion in the Fautrel diagnostic criteria for AOSD
- It has been correlated with early diagnosis in at least one study
- It is more specific for AOSD than total ferritin alone (which can be elevated in many conditions)
- It does not require exclusion criteria when used in the Fautrel set - giving it practical clinical advantage
Ferritin as a Disease Activity Marker
Ferritin levels track disease activity in AOSD:
- Levels rise during flares and fall during remission
- Serial monitoring of ferritin can guide treatment response
- Persistently very high levels despite treatment are a warning sign for complications (especially MAS)
Ferritin in MAS/HLH Complicating AOSD
When AOSD is complicated by Macrophage Activation Syndrome (MAS) - which occurs in approximately 10-15% of AOSD patients - ferritin rises to even more extreme levels and takes on critical diagnostic and prognostic importance.
MAS-HLH Diagnostic Threshold (2016 Criteria)
A febrile AOSD/sJIA patient with ferritin >684 μg/L PLUS any 2 of:
- Platelet count ≤181 × 10⁹/L
- AST >48 U/L
- Fasting triglycerides >156 mg/dL (>1.76 mmol/L)
- Fibrinogen ≤3.6 g/L
- Harrison's Principles of Internal Medicine, 22nd Ed., Ch. on MAS
Why Ferritin is so High in MAS
In MAS, macrophages are uncontrollably activated and phagocytose red blood cells and other blood cells (hemophagocytosis). These macrophages release enormous amounts of stored ferritin directly into the circulation. IL-18 levels are characteristically very high in MAS-HLH, distinguishing it from other HLH forms. The ferritin surge in MAS is therefore both quantitatively and mechanistically distinct from the already-elevated levels in uncomplicated AOSD.
Differential Diagnosis of Extreme Hyperferritinemia
Ferritin elevations in AOSD must be distinguished from other causes:
| Cause | Typical Ferritin Level | Distinguishing Features |
|---|---|---|
| AOSD | 4,000 - >50,000 ng/mL | Glycosylated fraction <20%, quotidian fever, salmon rash |
| MAS / HLH | Often >10,000 ng/mL | Cytopenias, hemophagocytosis on marrow bx, high triglycerides |
| Hemochromatosis | Usually <1,000 ng/mL (rarely higher) | High transferrin saturation, HFE mutation, normal glycosylated fraction |
| Sepsis / Severe infection | Variable, rarely >10,000 | Positive cultures, source identified |
| Lymphoma | High, variable | Atypical lymphadenopathy, LDH elevated, marrow/node biopsy |
| Histiocytosis | Can be >50,000 ng/mL | Bone marrow / tissue biopsy findings |
| Liver failure | Moderate to high | Coagulopathy, jaundice, transaminases grossly elevated |
| Hyperferritinemia-cataract syndrome | Elevated | Autosomal dominant, cataracts, FTL gene mutation, no iron overload |
Key principle from Yamada's Gastroenterology: Extreme elevations of serum ferritin (>50,000 μg/L) are usually NOT related to hemochromatosis - they point to histiocytosis and Still disease.
Summary: Ferritin-Specific Points in AOSD
| Parameter | Value/Finding |
|---|---|
| Total ferritin | Often >4,000 ng/mL; correlates with disease activity |
| Glycosylated ferritin fraction | <20% in AOSD (normal 50-80%) |
| Role in Fautrel criteria | Major criterion (fraction ≤20%) |
| MAS trigger level | >684 ng/mL + 2 other MAS criteria |
| Serial monitoring | Useful to assess treatment response and flare activity |
| Extreme elevation (>50,000) | Points to MAS complicating AOSD, or histiocytosis |
Practical Clinical Takeaways
- Order both total ferritin AND glycosylated ferritin fraction when AOSD is suspected - the ratio is the more specific test.
- A glycosylated fraction <20% in the context of fever, rash, and arthritis is essentially diagnostic until proven otherwise.
- A rising ferritin in a known AOSD patient should prompt urgent evaluation for MAS - check CBC for cytopenias, coagulation studies, LFTs, and triglycerides.
- Ferritin is not a reliable indicator of iron stores in AOSD - the elevation is driven by macrophage activation, not iron overload. Transferrin saturation and clinical context help distinguish the two.
- Ferritin normalization on treatment is a useful therapeutic target, though formal guidelines for ferritin-directed dosing do not yet exist.
Sources:
- Fitzpatrick's Dermatology, Vols 1-2 (McGraw-Hill), Ch. 66
- Dermatology 2-Volume Set, 5th Ed. (Elsevier), Ch. 45
- Harrison's Principles of Internal Medicine, 22nd Ed. (2025), MAS-HLH section
- Tietz Textbook of Laboratory Medicine, 7th Ed. - Serum Ferritin chapter
- Yamada's Textbook of Gastroenterology, 7th Ed. - Serum Ferritin section
- Macovei LA et al. Int J Mol Sci. 2022 [PMID: 36361602]
This is a shared conversation. Sign in to Orris to start your own chat.